Business Context and Reporting Period
Company: Capricor Therapeutics, Inc. (CAPR)
Filing Type: Form 8-K (Current Report)
Report Date: March 19, 2025
Reporting Period: Fourth Quarter and Full Year ended December 31, 2024
This filing serves as a notification that the Company issued a press release on March 19, 2025, announcing its financial results for the specified period. The detailed financial data is contained in Exhibit 99.1 (the press release), which is furnished but not deemed filed for purposes of Section 18 of the Exchange Act.
Key Financial Metrics
The provided text is a cover page and index for the Form 8-K and does not contain specific numerical data. Consequently, the following metrics are not available in this document:
- Revenue: Not provided in filing text.
- Profit/Loss: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Margins: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing text does not provide specific comparative data or details regarding material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for year-over-year or quarter-over-quarter analysis.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release titled "Capricor Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update," indicating that management commentary and a corporate update are included in the attached exhibit.
Guidance and Risks: Specific forward-looking guidance, risk factors, contingencies, or unusual items are not detailed in the provided text. The document explicitly states that the information is furnished and not incorporated by reference unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (the March 19, 2025 press release) for actual revenue, net loss, and cash position figures.
- Verify the specific details of the "Corporate Update" mentioned in the press release title for strategic shifts or pipeline progress.
- Check the Company's subsequent filings (e.g., 10-Q or 10-K) for audited or reviewed financial statements, as this 8-K only references the press release.
- Confirm the trading status of Common Stock (Symbol: CAPR) on The Nasdaq Capital Market.